THOMAS KOSTEN to Dopamine Plasma Membrane Transport Proteins
This is a "connection" page, showing publications THOMAS KOSTEN has written about Dopamine Plasma Membrane Transport Proteins.
Connection Strength
0.384
-
Pharmacogenetic role of dopamine transporter (SLC6A3) variation on response to disulfiram treatment for cocaine addiction. Am J Addict. 2019 07; 28(4):311-317.
Score: 0.155
-
Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders. Pharmacogenet Genomics. 2015 Jun; 25(6):296-304.
Score: 0.118
-
Addiction as a brain disease. Am J Psychiatry. 1998 Jun; 155(6):711-3.
Score: 0.036
-
Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal. Biol Psychiatry. 1998 Feb 15; 43(4):278-81.
Score: 0.036
-
Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry. 2000 Oct; 157(10):1700-3.
Score: 0.011
-
Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients. Am J Psychiatry. 2000 Jul; 157(7):1134-40.
Score: 0.010
-
Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. Am J Psychiatry. 1998 Jun; 155(6):832-4.
Score: 0.009
-
[123I]beta-CIT SPECT imaging of dopamine transporter availability after mazindol administration in human cocaine addicts. Psychopharmacology (Berl). 1998 Jun; 137(4):321-5.
Score: 0.009